Evaluation of primary standard cisplatin-based chemotherapy for clinical stage II non-seminomatous germ cell tumours of the testis.

Culine, S; Theodore, C; Court, B H; Perrin, J L; Droz, J P

Culine, S; Theodore, C; Court, B H; Perrin, J L; Droz, J P.

Affiliation

Culine S; Department of Medicine, Institut Gustave Roussy, Villejuif, France.

Br J Urol ; 79(2): 258-62, 1997 Feb.

Article in En | MEDLINE | ID: mdl-9052479

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Neoplasms, Germ Cell and Embryonal/drug therapy; Testicular Neoplasms/drug therapy; Adolescent; Adult; Bleomycin/administration & dosage; Cisplatin/administration & dosage; Cyclophosphamide/administration & dosage; Dactinomycin/administration & dosage; Endodermal Sinus Tumor/drug therapy; Endodermal Sinus Tumor/pathology; Etoposide/administration & dosage; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal/pathology; Seminoma/drug therapy; Seminoma/pathology; Teratoma/drug therapy; Teratoma/pathology; Testicular Neoplasms/pathology; Treatment Outcome; Vinblastine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Testicular Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoplasms, Germ Cell and Embryonal Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Humans / Male / Middle aged Language: En Journal: Br J Urol Year: 1997 Document type: Article Affiliation country: France Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links